Abstract
Purpose
The purpose of this study was to compare outcomes assessed in extant randomized controlled trials (RCTs) to outcomes that stakeholders expect from survivorship care plans (SCPs). To facilitate the transition from active treatment to follow-up care for the 15.5 million US cancer survivors, many organizations require SCP use. However, results of several RCTs of SCPs’ effectiveness have been null, possibly because they have evaluated outcomes on which SCPs should be expected to have limited influence. Stakeholders (e.g., survivors, oncologists) may expect outcomes that differ from RCTs’ outcomes.
Methods
We identified RCTs’ outcomes using a PubMed literature review. We identified outcomes that stakeholders expect from SCPs using semistructured interviews with stakeholders in three healthcare systems in the USA and Canada. Finally, we mapped RCTs’ outcomes onto stakeholder-identified outcomes.
Results
RCT outcomes did not fully address outcomes that stakeholders expected from SCPs, and RCTs assessed outcomes that stakeholders did not expect from SCPs. RCTs often assessed outcomes only from survivors’ perspectives.
Conclusions
RCTs of SCPs’ effectiveness have not assessed outcomes that stakeholders expect. To better understand SCPs’ effectiveness, future RCTs should assess outcomes of SCP use that are relevant from the perspective of multiple stakeholders.
Implications for Cancer Survivors
SCPs’ effectiveness may be optimized when used with an eye toward outcomes that stakeholders expect from SCPs. For survivors, this means using SCPs as a map to guide them with respect to what kind of follow-up care they should seek, when they should seek it, and from whom they should seek it.
Similar content being viewed by others
References
Ganz PA. Late effects of cancer and its treatment. Semin Oncol Nurse. 2001;17(4):241–8.
Urquhart R, Folkes A, Porter G, Kendell C, Cox M, Dewar R, et al. Population-based longitudinal study of follow-up care for colorectal cancer patients in Nova Scotia. J Oncol Pract. 2012;8(4):246–52.
Grunfeld E, Hodgson DC, Del Guidice ME, et al. Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract. 2010;6(4):174–81.
Hahn EE, Hays RD, Kahn KL, Litwin MS, Ganz PA. Use of imaging and biomarker tests for post-treatment care of early stage breast cancer survivors. Cancer. 2013;119(24):4316–26.
Hahn EE, Tang T, Lee JS, et al. Use of post-treatment imaging and biomarkers in early stake breast cancer survivors: inappropriate surveillance or necessary care? Cancer. 2016;122(6):908–16.
Cheung WY, Neville BA, Cameron DB, Cook EF, Earle CC. Comparisons of patient and physician expectations for cancer survivorship care. J Clin Oncol. 2009;27(15):2489–95.
Mallinger JB, Griggs JJ, Shields CG. Patient-centered care and breast cancer survivors’ satisfaction with information. Patient Educ Couns. 2005;57(3):342–9.
Nicolaije KA, Husson O, Ezendam NP, et al. Endometrial cancer survivors are unsatisfied with received information about diagnosis, treatment and follow-up: a study from the population-based PROFILES registry. Patient Educ Couns. 2012;88(3):427–35.
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41.
Institute of Medicine. In: Levit LA, et al., editors. Delivering high-quality cancer care: charting a new course for a system in crisis. Washington, DC: National Academy of Sciences; 2013.
National Cancer Survivorship Resource Center. Systems policy and practice: clinical survivorship care. Atlanta: American Cancer Society; 2011.
McCabe MS, Bhatia S, Oeffinger KC, et al. American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 2013;31(5):631–40.
Commission on Cancer, American Cancer Society. Cancer program standards 2012: ensuring patient-centered care. Atlanta: American Cancer Society; 2012.
Shalom MM, Hahn EE, Casillas J, Ganz PA. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract. 2011;7(5):314–8.
Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, et al. Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol. 2011;29(36):4755–62.
Boekhout AH, Maunsell E, Pond GR, et al. A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv. 2015;9:683–91.
Coyle D, Grunfeld E, Coyle K, et al. Cost effectiveness of a survivorship care plan for breast cancer survivors. J Oncol Pract. 2013;10(2):e86–92.
Brothers BM, Easley A, Salani R, Andersen BL. Do survivorship care plans impact patients’ evaluations of care? A randomized evaluation with gynecologic oncology patients. Gynecol Oncol. 2013;129(3):554–8.
Hershman DL, Greenlee H, Awad D, Kalinsky K, Maurer M, Kranwinkel G, et al. Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors. Breast Cancer Res Treat. 2013;138:795–806.
Nicolaije KA, Ezendam NP, Vos MC, et al. Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic cluster randomized trial. J Clin Oncol. 2015;33(31):3550–9.
de Rooij BH, Ezendam NP, Nicolaije KA, et al. Effects of survivorship care plans on patient reported outcomes in ovarian cancer during 2-year follow-up—the ROGY care trial. Gynecol Oncol. 2017;145(2):319–28.
Ruddy KJ, Guo H, Baker EL, Goldstein MJ, Mullaney EE, Shulman LN, et al. Randomized phase 2 trial of a coordinated breast cancer follow-up care program. Cancer. 2016;122:3546–54.
Nicolaije KA, Ezendam NP, Pijnenborg JM, et al. Paper-based survivorship care plans may be less helpful for cancer patients who search for disease-related information on the internet: results of the Registrationsystem Oncological Gynecology (ROGY) care randomized trial. J Med Internet Res. 2016;18(7):e162.
Ezendam NP, Nicolaije KA, Kruitwagen RF, et al. Survivorship care plans to inform the primary care physician: results from the ROGY care pragmatic cluster randomized controlled trial. J Cancer Surviv. 2014;8:595–602.
Maly RC, Liang L-J, Liu Y, et al. Randomized controlled trial of survivorship care plans among low-income, predominantly Latina breast cancer survivors. J Clin Oncol. 2017;35(16):1814–21.
Kvale EA, Huang CH, Meneses KM, et al. Patient-centered support in the survivorship care transition: outcomes from the patient-owned survivorship care plan intervention. Cancer. 2016;122:3232–42.
Smith KC, Tolbert E, Hannum SM, Radhakrishnan A, Zorn K, Blackford A, et al. Comparing web-based provider-initiated and patient-initiated survivorship care planning for cancer patients: a randomized controlled trial. JMIR Cancer. 2016;2(2):e12.
Nicolaije KA, Ezendam NP, Vos MC, et al. Oncology providers’ evaluation of the use of an automatically generated cancer survivorship care plan: longitudinal results from the ROGY care trial. J Cancer Surviv. 2014;8:248–59.
Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–204.
Glaser BG, Strauss AL. Awareness of dying. Chicago: Aldine; 1965.
Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine; 1967.
Glaser BG. Basics of grounded theory analysis: emergence vs. forcing. Mill Valley: Sociology Press; 1992.
What is patient experience? Content last reviewed March 2017. Agency for Healthcare Research and Quality, Rockville. http://www.ahrq.gov/cahps/about-cahps/patient-experience/index.html.
Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38(2):65–76.
Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res. 2008;27:32.
Parry C, Kent EE, Forsythe LP, Alfano CM, Rowland JH. Can’t see the forest for the care plan: a call to revisit the context of care planning. J Clin Oncol. 2013;31(21):2651–3.
Franco BB, Dharmakulaseelan L, McAndrew A, Bae S, Cheung MC, Singh S. The experiences of cancer survivors while transitioning from tertiary to primary care. Curr Oncol. 2016;23(6):378–85.
Norris JM, White DE, Nowell L, Mrklas K, Stelfox HT. How do stakeholders from multiple hierarchical levels of a large provincial health system define engagement? A qualitative study. Implement Sci. 2017;12:98.
Selove R, Birken SA, Skolarus TA, Hahn EE, Sales A, Proctor EK. Using implementation science to explain the impact of cancer survivorship care plans. J Clin Oncol. 2016;34(43):3834–7.
Nolte L, Kinnane N, Lai-Kwon J, Gates P, Shilkin P, Jefford M. The impact of survivorship care planning on patients, general practitioners, and hospital-based staff. Cancer Nurs. 2016;39(6):E26–35.
Reb A, Ruel N, Fakih M, Lai L, Salgia R, Ferrell B, et al. Empowering survivors after colorectal and lung cancer treatment: pilot study of a self-management survivorship care planning intervention. Eur J Oncol Nurs. 2017;29:125–34.
Patient Centered Outcomes Research Institute (PCORI). https://www.pcori.org/about-us.
Canadian Institutes of Health Research. Canada’s strategy for patient-oriented research. http://www.cihr-irsc.gc.ca/e/44000.html.
Chadder J, Zomer S, on behalf of the Canadian Partnership Against Cancer and provincial investigators. Experiences of cancer patients in transition. Canadian Partnership Against Cancer System Performance Initiative and Person-Centred Perspective Grant ($1,550,000; 2015–2017).
Mays N, Pope C. Rigour and qualitative research. BMJ. 1995;311:109–12.
Harman NL, Bruce IA, Kirkham JJ, Tierney S, Callery P, O'Brien K, et al. The importance of integration of stakeholder views in core outcomes set development: otitis media with effusion in children with cleft palate. PLoS One. 2015;10(6):e0129514.
Rowland JH, Ganz PA. Cancer survivorship plans: a paradigm shift in the delivery of quality cancer care. In: Feuerstein M, Ganz PA, editors. Health services for cancer survivors. New York: Springer; 2011. p. 169–85.
Funding
This publication was supported by Grant Number 15014 from the Cancer Research Network 2015 Opportunity Fund Program and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant KL2TR001109. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the awardee, subawardee, the Cancer Research Network, or the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The Institutional Review Board at the University of North Carolina at Chapel Hill exempted the study from human subjects review. The Research Ethics Board at NSHA and the Institutional Review Board at KPSC approved the study.
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Birken, S.A., Urquhart, R., Munoz-Plaza, C. et al. Survivorship care plans: are randomized controlled trials assessing outcomes that are relevant to stakeholders?. J Cancer Surviv 12, 495–508 (2018). https://doi.org/10.1007/s11764-018-0688-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-018-0688-6